Kathrin Schmeisser, PhD, has worked in two successful C. elegans laboratories (with Michael Ristow, ETH Zurich, and David Gems, University College London) and has been extensively trained in using C. elegans as model organism. More specifically, she was trained in genetic approaches to generate mutant strains and to investigate those lines using a broad range of techniques. Dr. Schmeisser constructed worm models to investigate the ortholog of the enzyme NNMT and described its role in mediating sirtuin functions and its impact in the overall aging process. After finishing her doctoral thesis, she was accepted to join the Chemical Biology Research Trainee program at McGill University, where she improved her skills in molecular biology. Subsequently, she joined the neuroscience lab of Dr. Alex Parker as a postdoctoral researcher, where she now uses her skills and knowledge to study Parkinson’s disease in the model organism C. elegans.